PETS Earnings & Financial Statements
PetMed Express, Inc.
$1.20
-$0.07(-5.51%)
32
Overall
60
Value
9
Tech
28
Quality
Market Cap
$26.01M
Volume
416.62K
52W Range
$1.27 - $4.10
Target Price
$1.40
PETS earnings and financial statements: PetMed Express, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PETS Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $179.02M | $226.97M | $274.10M | $256.58M | $273.42M |
| Cost of revenue | $2.10M | $157.84M | $189.33M | $185.84M | $195.34M |
| Operating income | -$58.67M | -$1.53M | -$8.16M | $6.05M | $25.71M |
| EBITDA | -$48.48M | $6.27M | $272.0K | $10.99M | $29.81M |
| Net income | -$57.29M | -$6.27M | -$7.46M | $5.14M | $21.10M |
| EPS (diluted) | $-2.74 | $-0.30 | $-0.37 | $0.01 | $1.04 |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total assets | $81.19M | $148.70M | $169.88M | $167.49M | $176.32M |
| Total liabilities | $52.25M | $63.57M | $73.15M | $57.51M | $34.13M |
| Shareholders’ equity | $28.94M | $85.13M | $96.73M | $109.97M | $142.19M |
| Cash and equivalents | $21.41M | $54.72M | $55.30M | $104.10M | $111.10M |
| Long-term debt | $42.0K | $535.0K | $995.0K | - | - |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | -$28.39M | $4.72M | $4.32M | $27.80M | $18.50M |
| Capital expenditure | -$4.62M | -$5.11M | -$4.51M | -$5.26M | -$1.75M |
| Free cash flow | -$33.01M | -$395.0K | -$194.0K | $22.54M | $16.75M |
| Dividends paid | $21.0K | $181.0K | $12.44M | $24.54M | $24.38M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PETS | $1.20 | -5.5% | 416.62K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |